Literature DB >> 23255788

Protein-primed terminal transferase activity of hepatitis B virus polymerase.

Scott A Jones1, Jianming Hu.   

Abstract

Hepatitis B virus (HBV) replication requires reverse transcription of an RNA pregenome (pgRNA) by a multifunctional polymerase (HP). HP initiates viral DNA synthesis by using itself as a protein primer and an RNA signal on pgRNA, termed epsilon (Hε), as the obligatory template. We discovered a Mn(2+)-dependent transferase activity of HP in vitro that was independent of Hε but also used HP as a protein primer. This protein-primed transferase activity was completely dependent on the HP polymerase active site. The DNA products of the transferase reaction were linked to HP via a phosphotyrosyl bond, and replacement of the Y63 residue of HP, the priming site for templated DNA synthesis, almost completely eliminated DNA synthesis by the transferase activity, suggesting that Y63 also serves as the predominant priming site for the transferase reaction. For this transferase activity, HP could use all four deoxynucleotide substrates, but TTP was clearly favored for extensive polymerization. The transferase activity was highly distributive, leading to the synthesis of DNA homo- and hetero-oligomeric and -polymeric ladders ranging from 1 nucleotide (nt) to >100 nt in length, with single-nt increments. As with Hε-templated DNA synthesis, the protein-primed transferase reaction was characterized by an initial stage that was resistant to the pyrophosphate analog phosphonoformic acid (PFA) followed by PFA-sensitive DNA synthesis, suggestive of an HP conformational change upon the synthesis of a nascent DNA oligomer. These findings have important implications for HBV replication, pathogenesis, and therapy.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23255788      PMCID: PMC3571375          DOI: 10.1128/JVI.02786-12

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  79 in total

1.  An 8 nt RNA triggers a rate-limiting shift of RNA polymerase II complexes into elongation.

Authors:  Aaron R Hieb; Sean Baran; James A Goodrich; Jennifer F Kugel
Journal:  EMBO J       Date:  2006-06-15       Impact factor: 11.598

2.  Base pairing between the 5' half of epsilon and a cis-acting sequence, phi, makes a contribution to the synthesis of minus-strand DNA for human hepatitis B virus.

Authors:  Teresa M Abraham; Daniel D Loeb
Journal:  J Virol       Date:  2006-05       Impact factor: 5.103

Review 3.  Hepatitis B virus genetic variability and evolution.

Authors:  Alan Kay; Fabien Zoulim
Journal:  Virus Res       Date:  2007-03-26       Impact factor: 3.303

4.  The use of non-natural nucleotides to probe template-independent DNA synthesis.

Authors:  Anthony J Berdis; David McCutcheon
Journal:  Chembiochem       Date:  2007-08-13       Impact factor: 3.164

5.  Nontemplated terminal nucleotidyltransferase activity of double-stranded RNA bacteriophage phi6 RNA-dependent RNA polymerase.

Authors:  Minna M Poranen; Minni R L Koivunen; Dennis H Bamford
Journal:  J Virol       Date:  2008-07-09       Impact factor: 5.103

Review 6.  Visualizing polynucleotide polymerase machines at work.

Authors:  Thomas A Steitz
Journal:  EMBO J       Date:  2006-08-09       Impact factor: 11.598

7.  Deamination-independent inhibition of hepatitis B virus reverse transcription by APOBEC3G.

Authors:  David H Nguyen; Suryaram Gummuluru; Jianming Hu
Journal:  J Virol       Date:  2007-02-21       Impact factor: 5.103

8.  Inhibition of hepadnavirus reverse transcriptase-epsilon RNA interaction by porphyrin compounds.

Authors:  Li Lin; Jianming Hu
Journal:  J Virol       Date:  2007-12-19       Impact factor: 5.103

9.  Chaperones activate hepadnavirus reverse transcriptase by transiently exposing a C-proximal region in the terminal protein domain that contributes to epsilon RNA binding.

Authors:  Michael Stahl; Jürgen Beck; Michael Nassal
Journal:  J Virol       Date:  2007-10-03       Impact factor: 5.103

10.  Functional and structural dynamics of hepadnavirus reverse transcriptase during protein-primed initiation of reverse transcription: effects of metal ions.

Authors:  Li Lin; Fen Wan; Jianming Hu
Journal:  J Virol       Date:  2008-04-09       Impact factor: 5.103

View more
  25 in total

1.  Non-nucleoside hepatitis B virus polymerase inhibitors identified by an in vitro polymerase elongation assay.

Authors:  Shogo Nakajima; Koichi Watashi; Kento Fukano; Senko Tsukuda; Kousho Wakae; Hideki Aizaki; Masamichi Muramatsu; Takaji Wakita; Tetsuya Toyoda
Journal:  J Gastroenterol       Date:  2019-11-25       Impact factor: 7.527

2.  Identification of an Intermediate in Hepatitis B Virus Covalently Closed Circular (CCC) DNA Formation and Sensitive and Selective CCC DNA Detection.

Authors:  Jun Luo; Xiuji Cui; Lu Gao; Jianming Hu
Journal:  J Virol       Date:  2017-08-10       Impact factor: 5.103

Review 3.  Hepadnavirus Genome Replication and Persistence.

Authors:  Jianming Hu; Christoph Seeger
Journal:  Cold Spring Harb Perspect Med       Date:  2015-07-01       Impact factor: 6.915

Review 4.  APOBECs and virus restriction.

Authors:  Reuben S Harris; Jaquelin P Dudley
Journal:  Virology       Date:  2015-03-26       Impact factor: 3.616

5.  Large-scale production and structural and biophysical characterizations of the human hepatitis B virus polymerase.

Authors:  Judit Vörös; Annika Urbanek; Gilles Jean Philippe Rautureau; Maggie O'Connor; Henry C Fisher; Alison E Ashcroft; Neil Ferguson
Journal:  J Virol       Date:  2013-12-18       Impact factor: 5.103

6.  Mapping of Functional Subdomains in the Terminal Protein Domain of Hepatitis B Virus Polymerase.

Authors:  Daniel N Clark; John M Flanagan; Jianming Hu
Journal:  J Virol       Date:  2017-01-18       Impact factor: 5.103

7.  Biochemical properties of bacterial reverse transcriptase-related (rvt) gene products: multimerization, protein priming, and nucleotide preference.

Authors:  Irina A Yushenova; Irina R Arkhipova
Journal:  Curr Genet       Date:  2018-05-14       Impact factor: 3.886

8.  Unveiling the roles of HBV polymerase for new antiviral strategies.

Authors:  Daniel N Clark; Jianming Hu
Journal:  Future Virol       Date:  2015       Impact factor: 1.831

Review 9.  Revisiting Hepatitis B Virus: Challenges of Curative Therapies.

Authors:  Jianming Hu; Ulrike Protzer; Aleem Siddiqui
Journal:  J Virol       Date:  2019-09-30       Impact factor: 5.103

10.  Noncompetitive inhibition of hepatitis B virus reverse transcriptase protein priming and DNA synthesis by the nucleoside analog clevudine.

Authors:  Scott A Jones; Eisuke Murakami; William Delaney; Phillip Furman; Jianming Hu
Journal:  Antimicrob Agents Chemother       Date:  2013-06-17       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.